PollenVax Subcutaneous Immunotherapy for Mugwort Pollen-Induced Allergic Rhinitis

计划入组 138 人 · 首次发布于 2026 年 5 月 4 日

Skin Testing With Recombinant Bet v 1 and Hypoallergenic Recombinant Bet v 1 Fragments

计划入组 30 人 · 首次发布于 2014 年 3 月 28 日

Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART Control

计划入组 69 人 · 首次发布于 2022 年 3 月 29 日

BDM-V-1

ART-446

ART-237

NHI-1

United States

ART Fertility Clinics LLC

United Arab Emirates

TOUCH ART - SAMEH FATHY

Egypt

Intranasal Monoclonal Antibody Therapy Shows Promise Against Mugwort Pollen Allergy in Preclinical Study

V Foundation Awards $1 Million Grant to CU Anschutz for Infant ALL Research Targeting Menin Inhibition

Advancing Personalized Medicine: The Rise of N-of-1 Therapies for Rare Diseases